Alan J Russell
Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 14SEC | EWTXEdgewise Therapeutics, Inc. | Sell | 3,23834,129 held (−9%) | $43.68 | $141K | -10.6% |
| Aug 14SEC | EWTXEdgewise Therapeutics, Inc. | Sell | 2,27331,856 held (−7%) | $43.68 | $99K | -10.6% |
| Aug 14SEC | EWTXEdgewise Therapeutics, Inc. | Sell | 39031,466 held (−1%) | $44.46 | $17K | -12.1% |
| Jul 2SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 130,35294,203 held (−58%) | $39.41 | $5.1M | -0.9% |
| Jul 2SEC | EWTXEdgewise Therapeutics, Inc. | Sell Plan | 69,64824,555 held (−74%) | $39.41 | $2.7M | -0.9% |
| Nov 13SEC | EWTXEdgewise Therapeutics, Inc. | Sell | 100,00023,400 held (−81%) | $21.12 | $2.1M | +84.9% |
- Sell
Chief Scientific Officer Alan J Russell sold $5.1M of EWTX at $39.41 — cuts the stake by 58%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Alan J Russell sold $2.7M of EWTX at $39.41 — cuts the stake by 74%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Alan J Russell sold $2.1M of EWTX at $21.12 — cuts the stake by 81%.